바이오모아 (BioMoa) — ADC · Antibody

8428프로그램 40FDA 승인

0오늘 방문

1,453누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

CGTBiologicstaleFirst Affiliated Hospital of Zh…Phase 2

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

HIV (Human Immunodeficiency Virus) · HIV (Human Immunodeficiency Virus)

#HIVHumanImmunodeficiencyVirus#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleFate TherapeuticsPreclinical

Genetically engineered NK cells (Genetically engineered NK cells)

Hematological Malignancy · Hematological Malignancy

#HematologicalMalignancy#CGT#Preclinical#세포유전치료#CAR-T+2

효능 ORR 0%임상시험 1상태 DISCONTINUED

AntibodystalePeking UniversityPhase 2

Dexamethasone, azacytidine, Pegaspargase, Tislelizumab (Dexamethasone, azacytidine, Pegaspargase, Tislelizumab)

NK/T Cell Lymphoma · NK/T Cell Lymphoma

#NKTCellLymphoma#Antibody#Phase2#항체#면역항체+4

임상시험 1상태 ACTIVE

CGTBiologicstaleAnhui Provincial HospitalPhase 1

NK cells infusion (NK cells infusion)

Immunotherapy · Immunotherapy

#Immunotherapy#CGT#Phase1#세포유전치료#CAR-T+2

효능 ORR 0%임상시험 1상태 ACTIVE

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Renal Cancer; Kidney Cancer · Renal Cancer

#RenalCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleHenan Cancer HospitalPhase 2

Anti-Trop2 CAR-NK cell (Anti-Trop2 CAR-NK cell)

Non-Small Cell Lung Cancer NSCLC · TROP2

#TROP2#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleBaylor College of MedicinePhase 1

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Relapsed Neuroblastoma; Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

CGTBiologicstaleNew Approaches to Neuroblastoma…Phase 2

Universal Donor (UD, Universal Donor, Universal Donor (UD) TGFβi NK Cells)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleJieyang People's HospitalPhase 1

anti-CD19/BCMA CAR NK cells (anti-CD19/BCMA CAR NK cells)

IgA Nephropathy (IgAN) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

CGTBiologicstaleMayo ClinicPhase 1

Alefacept (Alefacept)

Lymphoma · Lymphoma

#Lymphoma#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

CGTBiologicstaleBeijing BiotechPhase 2

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

Colorectal Cancer; Metastatic Colorectal Adenocarcinoma · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

AntibodystaleEssen BiotechPhase 2

pembrolizumab (Keytruda, EBNK-001 + IL-15 + Pembrolizumab)

Cancer; Sarcoma · Cancer

#Cancer#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 RECRUITING

CGTBiologicstaleInstitute of Hematology & Blood…Phase 1

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 1상태 ACTIVE

CGTBiologicstaleShantou University Medical Coll…Preclinical

SZ003 CAR-NK (SZ003 CAR-NK)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Preclinical#세포유전치료#CAR-T+2

임상시험 1상태 DISCONTINUED

CGTBiologicstalePrecision Biotech Taiwan Corp.Phase 2

donor-derived NK cell infusion (donor-derived NK cell infusion)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleSecond Affiliated Hospital of G…Phase 1

Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells (Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells)

Stage IV Ovarian Cancer; Testis Cancer, Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 1상태 RECRUITING

CGTBiologicstaleM.D. Anderson Cancer CenterPhase 2

C9/CD5CAR/IL-15 NK cells (C9/CD5CAR/IL-15 NK cells)

Hematological Malignancies · Hematological Malignancies

#HematologicalMalignancies#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

ADCBiologicstaleBayerPhase 1

BAY 3547926 (BAY 3547926)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

Anti-CD5 CAR NK cells (Anti-CD5 CAR NK cells)

T-ALL/Lymphoma · T-ALL/Lymphoma

#T-ALLLymphoma#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

CGTBiologicstaleCancer Institute and Hospital, …Phase 1

anti-PSMA CAR-NK (anti-PSMA CAR-NK)

Prostate Cancer Castration-resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleFate TherapeuticsPhase 1

Allogenic CAR NK cells with BCMA expression (FT576, FT576 (Allogenic CAR NK cells with BCMA expression))

Multiple Myeloma; Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 ACTIVE

CGTBiologicstaleUniversity of ArkansasPhase 2

ENK Cell Infusion (ENK Cell Infusion)

Asymptomatic Multiple Myeloma · Asymptomatic Multiple Myeloma

#AsymptomaticMultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2

임상시험 1상태 ACTIVE

CGTBiologicstaleGuangzhou Women and Children's …Phase 2

autologous NK cell plus GD2 antibody (autologous NK cell plus GD2 antibody)

Neuroblastoma; GD2 Antibody · GD2

#GD2#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

ADCBiologicstaleBayerPhase 1

BAY 3713391 (BAY 3713391)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

CGTBiologicstaleHebei Taihe Chunyu Biotechnolog…Phase 2

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

B-Cell Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

116 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 1,453

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

Genetically engineered NK cells (Genetically engineered NK cells)

Dexamethasone, azacytidine, Pegaspargase, Tislelizumab (Dexamethasone, azacytidine, Pegaspargase, Tislelizumab)

NK cells infusion (NK cells infusion)

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Anti-Trop2 CAR-NK cell (Anti-Trop2 CAR-NK cell)

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Universal Donor (UD, Universal Donor, Universal Donor (UD) TGFβi NK Cells)

anti-CD19/BCMA CAR NK cells (anti-CD19/BCMA CAR NK cells)

Alefacept (Alefacept)

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

pembrolizumab (Keytruda, EBNK-001 + IL-15 + Pembrolizumab)

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

SZ003 CAR-NK (SZ003 CAR-NK)

donor-derived NK cell infusion (donor-derived NK cell infusion)

Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells (Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells)

C9/CD5CAR/IL-15 NK cells (C9/CD5CAR/IL-15 NK cells)

BAY 3547926 (BAY 3547926)

Anti-CD5 CAR NK cells (Anti-CD5 CAR NK cells)

anti-PSMA CAR-NK (anti-PSMA CAR-NK)

Allogenic CAR NK cells with BCMA expression (FT576, FT576 (Allogenic CAR NK cells with BCMA expression))

ENK Cell Infusion (ENK Cell Infusion)

autologous NK cell plus GD2 antibody (autologous NK cell plus GD2 antibody)

BAY 3713391 (BAY 3713391)

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

Genetically engineered NK cells (Genetically engineered NK cells)

Dexamethasone, azacytidine, Pegaspargase, Tislelizumab (Dexamethasone, azacytidine, Pegaspargase, Tislelizumab)

NK cells infusion (NK cells infusion)

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Anti-Trop2 CAR-NK cell (Anti-Trop2 CAR-NK cell)

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Universal Donor (UD, Universal Donor, Universal Donor (UD) TGFβi NK Cells)

anti-CD19/BCMA CAR NK cells (anti-CD19/BCMA CAR NK cells)

Alefacept (Alefacept)

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

pembrolizumab (Keytruda, EBNK-001 + IL-15 + Pembrolizumab)

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

SZ003 CAR-NK (SZ003 CAR-NK)

donor-derived NK cell infusion (donor-derived NK cell infusion)

Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells (Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells)

C9/CD5CAR/IL-15 NK cells (C9/CD5CAR/IL-15 NK cells)

BAY 3547926 (BAY 3547926)

Anti-CD5 CAR NK cells (Anti-CD5 CAR NK cells)

anti-PSMA CAR-NK (anti-PSMA CAR-NK)

Allogenic CAR NK cells with BCMA expression (FT576, FT576 (Allogenic CAR NK cells with BCMA expression))

ENK Cell Infusion (ENK Cell Infusion)

autologous NK cell plus GD2 antibody (autologous NK cell plus GD2 antibody)

BAY 3713391 (BAY 3713391)

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Chidamide Combined with NKG2D CAR-NK Cell Therapy (Chidamide Combined with NKG2D CAR-NK Cell Therapy)

Genetically engineered NK cells (Genetically engineered NK cells)

Dexamethasone, azacytidine, Pegaspargase, Tislelizumab (Dexamethasone, azacytidine, Pegaspargase, Tislelizumab)

NK cells infusion (NK cells infusion)

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Anti-Trop2 CAR-NK cell (Anti-Trop2 CAR-NK cell)

i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells (i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells)

Universal Donor (UD, Universal Donor, Universal Donor (UD) TGFβi NK Cells)

anti-CD19/BCMA CAR NK cells (anti-CD19/BCMA CAR NK cells)

Alefacept (Alefacept)

EB-DUO-CAR-NK-CEA/GCC (EB-DUO-CAR-NK-CEA/GCC)

pembrolizumab (Keytruda, EBNK-001 + IL-15 + Pembrolizumab)

CD33/CLL1 dual CAR-NK cell (CD33/CLL1 dual CAR-NK cell)

SZ003 CAR-NK (SZ003 CAR-NK)

donor-derived NK cell infusion (donor-derived NK cell infusion)

Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells (Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells)